Atwood & Palmer Inc’s Regeneron Pharmaceuticals Position
Does Atwood & Palmer Inc own Regeneron Pharmaceuticals (REGN)? Yes — 42.3K shares worth $26M (+1.41% of its 13F portfolio) as of Q2 2026, up from 41.7K shares the prior filed quarter.
Position Value
$26M
Q2 2026
Shares
42.3K
% of Portfolio
+1.41%
Quarters Held
24
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 42.3K | $26M | +1.41% |
| Q1 2026 | 41.7K | $32M | +1.82% |
| Q4 2025 | 41.8K | $32M | +1.83% |
| Q3 2025 | 41.4K | $23M | +1.37% |
| Q2 2025 | 41.6K | $22M | +1.36% |
| Q1 2025 | 42.0K | $27M | +1.85% |
| Q4 2024 | 43.7K | $31M | +2.13% |
| Q3 2024 | 43.8K | $46M | +3.13% |
| Q2 2024 | 43.9K | $46M | +3.49% |
| Q1 2024 | 43.9K | $42M | +3.21% |
| Q4 2023 | 44.5K | $39M | +3.16% |
| Q3 2023 | 45.3K | $37M | +3.27% |
| Q2 2023 | 45.5K | $33M | +2.92% |
| Q1 2023 | 42.1K | $35M | +3.25% |
| Q4 2022 | 42.0K | $30M | +2.74% |
| Q3 2022 | 41.9K | $29M | +2.86% |
| Q2 2022 | 41.5K | $25M | +2.39% |
| Q1 2022 | 41.1K | $29M | +2.48% |
| Q4 2021 | 40.8K | $26M | +2.15% |
| Q3 2021 | 28.3K | $17M | +1.53% |
| Q2 2021 | 28.2K | $16M | +1.41% |
| Q1 2021 | 150 | $71,000 | +0.01% |
| Q4 2020 | 100 | $48,000 | +0.01% |
| Q3 2020 | 75 | $42,000 | +0.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atwood & Palmer Inc’s full portfolio or all institutional holders of REGN.